Skip to main content
. Author manuscript; available in PMC: 2014 Mar 19.
Published in final edited form as: Annu Rev Public Health. 2012 Jan 3;33:279–305. doi: 10.1146/annurev-publhealth-031811-124553

Table 6.

Summary of economic evaluations of brief counseling for smoking cessationa

Characteristics Ruger et al. [2008] (65) Meenan et al. [1998] (52) Barnett et al. [2008] (7) Akers et al. [2007] (1) Boyd et al. [2009] (12)
Method
Analysis type CEA, CUA CEA CEA CEA CEA, CUA
Model type RCT RCT Randomized trial Randomized trial Observational study
Framing
Setting and population Low-income pregnant women in Boston Hospitalized adult smokers in two acute-care hospitals in a large group-model HMO in Oregon and Washington Smoking mental health outpatients being treated for depression People in five northern states (Oregon, Washington, Idaho, Montana, Alaska) interested in quitting smokeless tobacco Smokers who accessed either of the cessation services between March and May 2007 in Glasgow, Scotland
Intervention (comparator) Motivational interviewing with nurse tailored to patient’s stage of readiness
Brief counseling
20-min bedside counseling session with health counselor, 12-min video, self-help materials, and one or two follow-up phone calls
Usual care
Brief contact (stop-smoking guide and referral list)
Stepped smoking cessation program
Self-help manual only
Assisted self-help (manual plus videotape and two supportive phone calls from tobacco cessation counselors)
One-to-one cessation support in pharmacies
Group counseling in the community
Self-quit attempt
Perspective Societal Implementing hospital Health care payer Societal, provider/agency National health system
Time horizon Lifetime 1 year 18 months 18 months 4 weeks, 1 year
Effects
Main outcome and benefits measure QALYs saved
Life years saved
Quit rates
Life years saved
Abstinence rates
Life years gained
Quit rates Quit rates
QALYs
Cost
Cost analysis (cost components) Direct program costs (intervention, travel, training)
Neonatal intensive care costs
Maternal health care costs (cardiovascular and lung diseases)
Intervention costs (identify patients, deliver counseling, follow-up) Costs of all smoking cessation services used by participants, including intervention and referral
Mental health care costs
Direct program costs (materials, postage, phone service, counselor and staff time)
Participant and supporter’s time
Intervention costs incurred by National Health Service (NRT, professional time, overhead, materials used)
Base year (costs) 1997 1994 2003 2000 2007
Source (costs) Program records, published estimates Project surveys, expense reports, retrospective labor estimates, HMO’s financial staff, literature estimates Retail cost, Medicare reimbursement rates, hospital charge data, Red Book prices Material cost in bulk, Oregon minimum wage Resource use, National Health Service records
Results
Summary results For smoking cessation, intervention was more costly and less effective than usual care
For relapse prevention, the cost-effectiveness of the intervention was $851 per life year saved and $628 per QALY saved
Cost of intervention was $159 per smoker
Incremental cost per incremental quit was $3,697
Incremental cost per incremental discounted life year saved ranged from $1,691 to $7,444
Smoking cessation services cost $6,204 per successful quit or $5,170 per life year gained
Cessation services and mental health care cost $11,496 per successful quit or $9,580 per life year gained
Total cost per participant from societal and provider perspective, respectively, was $0 and $0 for no treatment, $20 and $8 for manual only, and $56 and $39 for assisted self-help
Incremental cost per quit from societal and provider perspective, respectively, was $691 and $264 for manual only and $1,131 and $973 for assisted self-help
Incremental cost per 4-week quitter was $1,512 for pharmacy support and $2,158 for group support compared with self-quit cessation attempts
Incremental cost per QALY gained was $8,620 for pharmacy services and $10,579 for group services
Characteristics Haile et al. [2002] (40) Thavorn et al. [2008] (75) Dino et al. [2008] (25) Solberg et al. [2006] (70) Cummings et al. [1989] (24)
Method
Analysis type CEA CEA CEA CUA CEA
Model type Cohort Markov model Markov transition model Not available Not available
Framing
Setting and population All smokers attending a noncardiac surgical preadmission clinic in Australia Two simulated cohorts of Thai smokers ages 40, 50, and 60 years who regularly smoke 10–20 cigarettes per day Students aged 17–25 years who smoke 5+ cigarettes per day in selected Florida schools Hypothetical group of patients in primary care clinics in the United States Hypothetical group of patients who are smokers and are seen during a routine office visit
Intervention (comparator) Structured, interactive computerized smoking cessation program Structured community pharmacist-based smoking cessation program (personalized and supportive advice, assessment, therapy, self-help material, follow-up visits)
Usual care (assessment, brief advice and support, therapy without follow-up care)
N-O-T teen smoking cessation program
20-min brief intervention
Model 1: one-time counseling
Model 2: model 1 + costs of smoking-attributable illness
Model 3: annual counseling
Model 4: model 3 + costs of smoking-attributable illness
4 min physician counseling patients to quit smoking during routine office visit
Perspective Hospital/payer Health care system School Societal Societal
Time horizon 2 months, 1 year Lifetime Age 25 Lifetime Not available
Effects
Main outcome and benefits measure Quit rates
Acceptability of computerized smoking cessation intervention
Life years gained Quit rates
Life years saved
QALYs Quit rates
Life years saved
Cost
Cost analysis (cost components) Cost of intervention (developing program, computer hardware, and software) Intervention costs (pharmacist training, fee, medications)
Direct medical costs of smoking-related diseases (COPD, lung cancer, stroke, cardiovascular disease)
Direct intervention costs (training costs, room/board for trainer, brochures, and gifts) Intervention costs (clinician time, medication, patient time/travel)
Costs of preventable smoking-attributed illness
Physician time spent counseling
Cost of self-help materials
Base year (costs) Not available (study in 1999) 2005 2000 2000 1984
Source (costs) Invoice Published studies, information centers, price index Program/school records Medicare reimbursement rates, wholesale costs, health care charges Average charges physician visit, cost of materials
Results
Summary results Costs of intervention at one year was $5.80 per patient, $24.19 per smoker and $271.47 per quitter At age 40, program resulted in cost savings to health system of $500 and $614 and 0.18 life years gained and 0.24 life years gained for men and women, respectively Incremental cost effectiveness ratio for N-O-T program was $443 per discounted life year saved in base model ($1,029 worst-case scenario, $274 best-case scenario) Cost-effectiveness was $1,100 and $2,266 per QALY saved for model 1 and 3, respectively
Model 2 and 4 were cost-saving with a net cost of $65 and $542 saved per smoker counseled
Brief advice cost $705–$988 per life year saved for men and $1,204–$2,058 per life year saved for women
a

Abbreviations: BENESCO, benefits of smoking cessation on outcomes; COPD, chronic obstructive pulmonary disease; CHD, coronary heart disease; CBA, cost-benefit analysis; CEA, cost-effectiveness analysis; CUA, cost-utility analysis; HECOS, health and economic consequences of smoking; HMO, health maintenance organization; N-O-T, Not On Tobacco smoking cessation program; NRT, nicotine replacement therapy; QALYs, quality-adjusted life years; RCT, randomized-controlled trial.